November 13th, 2026American Cancer Society Updates Prostate Cancer Screening GuidelinesThe ACS 2026 prostate cancer screening guidelines recommend risk-based PSA testing beginning at age 45 or 50, with updated follow-up thresholds.Read more
October 14th, 2026FDA Grants Breakthrough Device Designation to Natera's Multi-Cancer Early Detection Blood TestThe FDA granted Breakthrough Device designation to Natera's cell-free DNA multi-cancer early detection assay. What it means for primary care.Read more
October 13th, 2026Most Adolescents With Colorectal Cancer Diagnosed at Advanced Stage, Study FindsMost adolescents with sporadic colorectal cancer present with stage III or IV disease, and few have a family history, per data presented at AAP 2026.Read more
October 12th, 2026Updated Freenome CRC Blood Test Detects 18.2% of Advanced Precancerous LesionsFreenome reports 18.2% sensitivity for advanced precancerous lesions and 80.4% for colorectal cancer with its updated blood screening test.Read more